Drug Trial Radar · NCT06617715
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
3,080
Planned (sponsor's estimate)
Start
Oct 23, 2024
Primary completion
May 12, 2026
Study completion Jul 30, 2026
Sponsor
- Lead sponsor
- Sinovac Life Sciences Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 27, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 6 weeks, up to 5 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Phase Ⅲ clinical trial of 13-valent pneumococcal conjugate vaccine (PCV13) developed by Sinovac Life Science Co., Ltd will be conducted in pediatric population aged 2 months (minimum 6 weeks)-5 years (before 6th birthday). The objective of the study is to evaluate the immunogenicity and safety of Sinovac PCV13.
Conditions
- Pneumococcal Infectious Disease
Interventions
Sinovac PCV13Biological
One dose of Sinovac PCV13 (0.5 mL) is administered intramuscularly.
Prevnar®Biological
One dose of Prevnar® (0.5 mL) is administered intramuscularly.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of pneumococcal serotype-specific IgG antibody concentration ≥0.35 μg/ml (seropositive rate)Time frame: 30 days after primary vaccination
- Pneumococcal serotype-specific IgG antibody geometric mean concentration (GMC)Time frame: 30 days after primary vaccination
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Henan Provincial Center for Disease Control and Prevention
Zhengzhou, Henan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.